Telo Historical Income Statement
| TELO Stock | CAD 0.12 0.01 9.09% |
Historical analysis of Telo Genomics income statement accounts such as Interest Expense of 7.1 K, Research Development of 834.8 K, Cost Of Revenue of 55.4 K or Net Interest Income of 0.0 can show how well Telo Genomics Corp performed in making a profits. Evaluating Telo Genomics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Telo Genomics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Telo Genomics Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Telo Genomics Corp is a good buy for the upcoming year.
Telo |
About Telo Income Statement Analysis
Telo Genomics Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Telo Genomics shareholders. The income statement also shows Telo investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Telo Genomics Income Statement Chart
Add Fundamental
Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Telo Genomics Corp financial statement analysis. It represents the amount of money remaining after all of Telo Genomics Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Telo Genomics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Telo Genomics Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telo Genomics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. At this time, Telo Genomics' Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to climb to 7,065 in 2024, whereas Other Operating Expenses is likely to drop slightly above 2.3 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Cost Of Revenue | 57.0K | 33.1K | 38.1K | 55.4K | Research Development | 1.1M | 1.4M | 1.6M | 834.8K |
Telo Genomics income statement Correlations
Click cells to compare fundamentals
Telo Genomics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Telo Genomics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 64.7K | 62.2K | 57.0K | 33.1K | 29.8K | 54.5K | |
| Selling General Administrative | 946.1K | 653.3K | 986.6K | 1.5M | 1.7M | 1.6M | |
| Other Operating Expenses | 1.3M | 1.3M | 2.1M | 2.8M | 3.2M | 2.3M | |
| Operating Income | (1.2M) | (1.1M) | (2.1M) | (2.8M) | (2.5M) | (2.7M) | |
| Ebit | (1.2M) | (1.1M) | (2.1M) | (2.8M) | (2.5M) | (2.7M) | |
| Ebitda | (1.2M) | (1.0M) | (2.1M) | (2.8M) | (2.5M) | (2.6M) | |
| Total Operating Expenses | 1.3M | 1.3M | 2.1M | 2.8M | 3.2M | 2.3M | |
| Income Before Tax | (1.2M) | (1.1M) | (2.1M) | (2.8M) | (2.5M) | (2.7M) | |
| Total Other Income Expense Net | 95.7K | 187.2K | (5.4K) | (5.2K) | (6.0K) | (6.3K) | |
| Net Income | (1.2M) | (1.1M) | (2.1M) | (2.8M) | (2.5M) | (2.7M) | |
| Gross Profit | (64.7K) | (62.2K) | (57.0K) | (33.1K) | (29.8K) | (31.3K) | |
| Net Income From Continuing Ops | (1.2M) | (1.1M) | (2.1M) | (2.8M) | (3.2M) | (3.4M) | |
| Research Development | 364.7K | 603.9K | 1.1M | 1.4M | 1.6M | 834.8K | |
| Cost Of Revenue | 64.7K | 62.2K | 57.0K | 33.1K | 38.1K | 55.4K | |
| Net Income Applicable To Common Shares | (1.1M) | (1.2M) | (1.1M) | (2.1M) | (2.4M) | (2.5M) | |
| Reconciled Depreciation | 64.7K | 62.2K | 57.0K | 33.1K | 29.8K | 28.3K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Telo Stock Analysis
When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.